To evaluate the prevalence of β3-adrenergic receptor (ADRB3) Trp64Arg polymorphism and its relationship with the metabolic syndrome in severe obesity.
Cross-sectional outpatients study.
Patients and methods:
In 265 (100 men) severely obese non-diabetic subjects and 78 (25 men) healthy volunteers, genomic DNA was isolated from peripheral leukocytes. In obese patients, plasma concentrations of leptin, lipids, glucose and insulin, the homeostasis model assessment index and blood pressure have been measured. The Trp64Arg mutation was identified with the real-time TaqMan method.
Neither genotype distribution nor allele frequency differed between the two groups. The metabolic syndrome prevalence was 59% in obese subjects, and was higher in men than in women (65 vs 55%: P=0.03). The body mass index (BMI) was related to age tertiles (β=0.08; P<0.001; multiple linear regression) in Trp64Arg-positive obese subjects.
We confirm the high prevalence of the metabolic syndrome among severely obese subjects. ADRB3 polymorphism was significantly related to insulin resistance only in obese male subjects. Moreover, increased BMI was related to age in obese subjects with the ADRB3 polymorphism.
MIUR, COFIN 2004.
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Adams TD, Hunt SC, Mason LA, Ramirez ME, Fisher AG, Williams RR (1993). Familial aggregation of morbid obesity. Obes Res 1, 261–270.
Afonina IA, Zivarts M, Kutyavin IV, Lukhtanov EA, Gamper H, Meyer RB (1997). Efficient priming of PCR with short oligonucleotides conjugated to a minor groove binder. Nucleic Acids Res 25, 2657–2660.
Allison DB, Heo M, Faith MS, Pietrobelli A (1998). Meta-analysis of the association of the Trp64Arg polymorphism in the beta 3-adrenergic receptor with body mass index. Int J Obes Relat Metab Disord 22, 559–566.
Arch JRS, Kaumann AJ (1993). β3 and atypical β-adrenoceptors. Med Res Rev 13, 663–729.
Arner P (2000). Hunting for human obesity genes? Look in the adipose tissue. Int J Obes Relat Metab Disorder 24, S57–S62.
Astrup A, Raben A, Buemann B, Toubro S (1997). Fat metabolism in the prediction to obesity. Ann NY Acad Sci 827, 417–428.
Awata T, Katayama S (1996). Genetic variation in the β3-adrenergic receptor in Japanese NIDDM patients. Diabet Care 19, 271–272.
Candelore MR, Deng L, Tota LM, Kelly LJ, Cascieri MA, Strader D (1996). Pharmacological characterization of a recently described human β3-adrenergic receptors in obesity. Endocrinology 137, 2638–2641.
Clement K, Vaisse C, Manning BJ, Basdevant A, Guy-Grand B, Ruiz J et al. (1995). Genetic variation in the β3-adrenergic receptor and an increase capacity to gain weight in patient with morbid obesity. N Engl J Med 333, 352–354.
Corella D, Guillén M, Portolés O, Sorlì JV, Alonso V, Folch J et al. (2001). Gender specific associations of the Trp64Arg mutation in the β3-adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population: interaction with a common lipoprotein lipase gene variation. Int J Obes Relat Metab Disord 25, 348–360.
Evans D, Minouchher S, Hagemann G, Mann WA, Wendt D, Wolf A et al. (2000). Frequency of and interaction between polymorphisms in the β3-adrenergic receptor and in uncoupling proteins 1 and 2 and obesity in Germans. Int J Obes Relat Metab Disord 24, 1239–1245.
Flegal KM, Carroll MD, Ogden CL (2002). Prevalance and trends in obesity among US adults, 1999–2000. JAMA 288, 1723–1727.
Friedewald WT, Levy RI, Frederickson DS (1972). Estimation of the concentration of low density lipoprotein in plasma without use of a preparative ultracentrifuge. Clin Chem 18, 449–456.
Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T (1998). Meta-analysis of the association of Trp64Arg polymorphism of beta 3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 83, 2441–2444.
Gagnon J, Mauriege P, Roy S, Sjostrom D, Chagnon YC, Dionne FT et al. (1996). The Trp64Arg mutation of the β3-adrenergic receptor gene has no effect on obesity phenotypes in the Quebec family study and Swedish obese subjects cohorts. J Clin Invest 98, 2086–2093.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. (2005). Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation 25, 2735–2752.
Hoffstedt L, Poirier O, Thörne A, Lönnqvist F, Herrmann SM, Cambien F et al. (1999). Polymorphism of the human β3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes 48, 203–205.
Kadowaki H, Yasuda K, Iwamoto K, Otabe S, Shimokawa K, Silver K et al. (1995). A mutation in the β3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 215, 555–560.
Katzmarzyk P, Perusse L, Bouchard C (1999). Genetics of abdominal visceral fat levels. Am J Hum Biol 11, 225–235.
Krief S, Lönnqvist F, Raimbault S, Baude B, Van Spronsen A, Arner P et al. (1993). Tissue distribution of β3-adrenergic receptor mRNA in man. J Clin Invest 91, 344–349.
Kurokawa N, Nakai K, Kameo S, Liu ZM, Satoh H (2001). Association of BMI with the β3-adrenergic receptor gene polymorphism in Japanese: meta-analysis. Obes Res 9, 741–745.
Kutyavin IV, Afonina IA, Mills A, Gorn VV, Lukhtanov EA, Belousov ES et al. (2000). 3′-minor groove binder-DNA probes increase sequence specificity at PCR extention temperatures. Nucleic Acids Res 28, 655–661.
Livak KJ (1999). Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal Biomol E 14, 143–149.
Lofontan M, Berlan M (1993). Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 34, 1057–1091.
Lönnqvist F, Krief S, Strsberg AD, Nyberg S, Emorine LJ, Amer P (1995). A pathogenic role of visceral fat β3-adrenoceptors in obesity. J Clin Invest 95, 1109–1116.
Luke A, Durazo-Arvizu R, Rotimi C, Prewitt TE, Ferrester T, Wilks R et al. (1997). Relation between body mass index and body fat in black population samples from Nigeria, Jamaica and the United States. Am J Epidemiol 145, 620–628.
Marra M, Scalfi L, Contaldo F, Pasanisi F (2004). Fasting respiratory quotient as a predictor of long-term weight changes in non-obese women. Ann Nutr Metab 48, 189–192.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC et al. (1985). Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.
Moriarty M, Wing RR, Kuller LH, Ferrel RE (1997). Trp64Arg substitution in the b3-adrenergic receptor does not relate to body weight in healthy, premenopausal women. Int J Obes Relat Metab Disord 21, 829.
Oksanen L, Mustajoki P, Kaprio J, Kainulainen K, Janne O, Peltonen L et al. (1996). Polymorphism of the β3-adrenergic receptor gene in morbid obesity. Int J Obes 20, 1055–1061.
Perfetti R, Hui H, Chamie K, Binder S, Seibert M, McLenithan J et al. (2001). Pancreatic beta-cells expressing the Arg64 variant of the beta(3)-adrenergic receptor exhibit abnormal insulin secretory activity. J Mol Endocrinol 27, 133–144.
Pietri-Rouxel F, Manning BSTJ, Gros J, Strosberg AD (1997). The biochemical effect of the naturally occurring Trp64Arg mutation on human β3-adrenoceptor activity. Eur J Biochem 247, 1174–1179.
Price RA, Ness R, Laskarzewski P (1990). Common major gene inheritance of extreme overweight. Hum Biol 62, 747–765.
Seals DR, Bell C (2004). Chronic sympathetic activation: consequence and cause of age-associated obesity? Diabetes 53, 276–284.
Seidell JC, Muller DC, Sorkin JD, Andres R (1992). Fasting respiratory exchange ratio and resting metabolic rate as predictors of weight gain: the Baltimore longitudinal study. Int J Obes 16, 667–674.
Shiwaku K, Gao TQ, Isobe A, Fukushima T, Yamane Y (1998). A Trp64Arg mutation in the β3-adrenergic receptor gene is not associated with moderate overweight in Japanese workers. Metabolism 47, 1528–1530.
Snitker S, Odeleye OE, Hellmer J, Boschmann M, Monroe MB, Shuldiner AR et al. (1997). No effect of the Trp64Arg β3-adrenoceptor variant on in vivo lipolysis in subcutaneous tissue. Diabetologia 40, 838–842.
Strazzullo P, Iacone R, Siani A, Cappuccio FP, Russo O, Barba G et al. (2001). Relationship of Trp64Arg polymorphism of the beta3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti prospective heart study. J Hypertens 19, 399–406.
Thomas GN, Tomlison B, Chan JC, Young RP, Critchley JA (2000). The Trp64Arg polymorphism of the beta3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int J Obes Relat Metab Disord 24, 545–551.
Ueda K, Tanizawa Y, Oota Y, Inoue H, Kizuki N, Inoue H et al. (1997). Prevalence of the Trp64Arg missense mutation of the β3-adrenergic receptor gene in japanese subjects. Metabolism 46, 199–202.
Ukkola O, Rankinen T, Weisnagel SJ, Sun G, Perusse L, Chagnon YC et al. (2000). Interaction among the α2-, β2- and β3-adrenergic receptor genes and obesity-related phenotypes in the Quebec family study. Metabolism 49, 1063–1070.
Urhammer SA, Clausen JO, Hansen T, Pedersen O (1996). Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the β3-adrenergic receptor gene. Diabetes 45, 1115–1120.
Walston J, Silver K, Hilfiker H, Andersen RE, Seibert M, Beamer B et al. (2000). Insulin response to glucose is lower in individuals homozygous for the Arg64 variant of the beta-3-adrenergic receptor. J Clin Endocrinol Metab 85, 4019–4022.
Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S et al. (1995). Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3-adrenergic-receptor-gene. N Engl J Med 333, 343–347.
Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC (1995). Association of a polymorphism in the β3-adrenergic-receptor-gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333, 348–351.
Yoshida T, Sakane N, Umekawa T, Sakai M, Takahashi T, Kondo M (1995). Mutation of β3-adrenergic receptor of obesity. Lancet 246, 1433–1434.
Zaagsma J, Nahorski SR (1990). Is the adipocyte β-adrenoceptor a prototype for the recently cloned atypical β3-adrenoceptor? Trends Pharmacol Sci 11, 3–7.
This work was supported by grants from the Ministero delĺIstruzione, delĺUniversità e della Ricerca; COFIN 2004.
About this article
Cite this article
Bracale, R., Pasanisi, F., Labruna, G. et al. Metabolic syndrome and ADRB3 gene polymorphism in severely obese patients from South Italy. Eur J Clin Nutr 61, 1213–1219 (2007). https://doi.org/10.1038/sj.ejcn.1602640
- severe obesity
- metabolic syndrome
- ADRB3 polymorphism
Communications Biology (2021)
ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1
Lipids in Health and Disease (2018)
Association of adrenergic receptor gene polymorphisms in gallbladder cancer susceptibility in a North Indian population
Journal of Cancer Research and Clinical Oncology (2014)
The absence of polymorphisms in ADRB3, UCP1, PPARγ, and ADIPOQ genes protects morbid obese patients toward insulin resistance
Journal of Endocrinological Investigation (2012)